Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma

HPB

Volumn 15, Issue 4, 2013, Pages 260-264

  McNally, Megan E ^a   Collins, Amy ^b   Wojcik, Sylwia E ^d   Liu, James ^c   Henry, Jon C ^b   Jiang, Jinmai ^e   Schmittgen, Thomas ^e   Bloomston, Mark ^a  

^a Division of Surgical Oncology   (United States)

^b Department of General Surgery ^*  (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; MICRORNA; MICRORNA 126; MICRORNA 151 3P; UNCLASSIFIED DRUG;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT FISTULA; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PROTEIN EXPRESSION; SEPSIS; SURGICAL MORTALITY; TUMOR GROWTH; UPREGULATION;

EID: 84874686039     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00523.x     Document Type: Article

References (30)

1. Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M,. (2009) Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg 208: 134-147.
2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD,. (2005) Cholangiocarcinoma. Lancet 366: 1303-1314.
3. Shaib YH, Davila JA, McGlynn K, El-Seraq HB,. (2004) Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40: 472-477.
4. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y,. (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238: 720-727.
5. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al,. (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230: 808-818.
6. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M,. (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230: 663-671.
7. Baton O, Azoulay D, Adam DV, Castaing D,. (2007) Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 204: 250-260.
8. Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, et al,. (2002) Improved survival in resected biliary malignancies. Surgery 132: 555-563.
9. Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, et al,. (2005) Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 137: 396-402.
10. Yachimski P, Pratt DS,. (2008) Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol 42: 178-190.
11. Croce CM,. (2008) Oncogenes and cancer. N Engl J Med 358: 502-511.
12. Fortina P, Surrey S,. (2008) Digital mRNA profiling. Nat Biotechnol 26: 293-294.
13. Collins A, Wojcik S, Frankel W, Alder H, Yu L, Croce CM, et al,. (2011) A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. J Am Coll Surg 213 (Suppl.): 133 [Abstract].
14. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A,. (2010) AJCC Cancer Staging Manual, 7th edn. New York, Springer.
15. Chen L, Yan H-X, Yang W, Hu L, Yu LX, Liu Q, et al,. (2009) The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 50: 358-369.
16. Mott JL, Kobayashi S, Bronk SF, Gores GJ,. (2007) Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140.
17. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, et al,. (2009) MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death and tissue inhibitor of metalloproteinase. Gastroenterology 49: 1595-1601.
18. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al,. (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129.
19. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D,. (2011) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog. doi: 10.1002/mc.21864 [Epub ahead of print].
20. Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y, et al,. (2011) Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS ONE 6: e23584.
21. Luedde T,. (2010) MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumour cell migration and spreading of hepatocellular carcinoma. Hepatology 52: 1164-1166.
22. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, et al,. (2008) MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 373: 607-612.
23. Musiyenko A, Bitko V, Barik S,. (2008) Ectopic expression of miR-126, an intronic product of the vascular endothelial EGF-like 7 gene, regulates protein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med (Berl) 86: 313-322.
24. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K,. (2008) The non-coding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signalling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47: 939-946.
25. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G,. (2009) Epigenetic therapy upregulates the tumour suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379: 726-731.
26. Feng R, Chen X, Yu Y, Su L, Yu B, Li J, et al,. (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298: 50-63.
27. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y,. (2011) MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS ONE 6: e16617.
28. Meister J, Schmidt MHH,. (2010) miR-126 and miR-126: new players in cancer. Sci World J 10: 2090-2100.
29. Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M,. (2010) Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 17: 991-997.
30. Patel SH, Kooby DA, Staley CA III, Sarmiento JM, Maithel SK,. (2011) The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? HPB 13: 605-611.